Search Results 371-380 of 19258 for Myocardium

1. Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects - Mayo Clinic

   important valvular, coronary, myocardial or conduction abnormality,; hypertrophic cardiomyopathy or known or probable genetic arrhythmia; a contraindication ...

2. Selinexor in Advanced Liposarcoma - Clinical Trials

   Unstable angina or myocardial infarction within 3 months of enrollment;; Serious and potentially life-threatening arrhythmia. Patients with known central ...

3. A Study Comparing Nicotine Lozenges to Tobacco-Free Snuff for Reducing the Use of Smokeless Tobacco - Mayo Clinic

   Describe having a medical history of. Unstable angina; Myocardial infarction within the past 6 months; Cardiac dysrhythmia other than medication-controlled ...

4. Small vessel disease - Symptoms & causes - Mayo Clinic

   Alternative causes of myocardial ischemia in women: An update on spontaneous coronary artery dissection, vasospastic angina and coronary microvascular ...

5. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

   Selective clonal T-cell populations infiltrating the myocardium were identical to those present in tumors and skeletal muscle. Pharmacovigilance studies ...

6. Department of Molecular Pharmacology and Experimental Therapeutics Research - Overview

   Cardiac regeneration after myocardial infarction. Individual variation in response to antidepressants, or heart failure or cancer treatment. New ways to ...

7. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

   after completion of antiviral therapy). Clinically significant cardiac disease, including: myocardial infarction within 6 months before randomization, or ...

8. The Purpose of This Study is to Compare the Efficacy and Safety of Aficamten (CK-3773274) Compared With Metoprolol Succinate in Adults With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction - Mayo Clinic

   ≥ 15 mm in one or more myocardial segments OR 2. ≥ 13 mm in one or more wall segments and a known disease-causing gene mutation or positive family history ...

9. Safety And Potential Bioactivity Of CLBS16 In Patients With Coronary Microvascular Dysfunction And Without Obstructive Coronary Artery Disease - Mayo Clinic

   Myocardial infarction within 90 days prior to consent or between consent and treatment with CLBS16. Prior evidence of obstructive heart disease including ...

10. Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    History of myocardial infarction within 6 to 12 months (patients with history of myocardial infarction within 6 months are excluded from the study); Prior ...